silencing efficacy. We next identified several guanine modifications that alleviated neurotoxicity. In particular, 7-deazaguanine modification reduced CNS toxicity while maintaining the silencing activity of the ASOs. Our findings provide useful insights into nucleobase-dependent neurotoxicity and suggest a promising strategy involving guanine modifications to mitigate ASO-induced neurotoxicity without compromising therapeutic efficacy for the treatment of CNS diseases.